Unfold My Darkness || Momentum + Long-Term Investing View || Stock Analysis || Not SEBI Registered || I Share Unfiltered Updates - So Don’t Trust Me Blindly
India
Joined September 2020
- Tweets52.6K
- Following96
- Followers2.6K
- Likes1.8K
Pinned Tweet
I share mostly unfiltered updates, news, market activity, and occasional result breakdowns. These are not recommendations.
This space is more about tracking my process than building an audience. X (Twitter) is my personal research notebook (DeepTrack).
Do not rely on my posts blindly. Always do your own research before investing.
Content Overview:
1. Company Updates:
I mostly share positive developments and may skip negative news.
🔴Risk: Missing negative signals can be dangerous. Always verify both sides.
2. Quarterly Results:
I share result summaries and key highlights based on available data.
🔴Risk: May not cover complete financial context (including all negatives or one-offs). Always review full results.
3. Penny Stocks:
🔴Risk: Very high
Note: Highly volatile and prone to manipulation. Deep research is essential.
4. Illiquid Stocks:
🔴Risk: Very high
Note: Low volumes can make entry and exit difficult and impact prices.
5. Small-Cap Stocks:
🔴Risk: High
Note: High growth potential but volatile. Requires careful analysis.
6. Mid-Cap Stocks:
🔴Risk: Moderate
Note: More stable than small caps but still need due diligence.
7. Large-Cap Stocks:
🔴Risk: Relatively lower
Note: More stable, but fundamentals and valuations still matter.
InfoBeans Technologies Ltd - Achieves Select Partner Tier in Anthropic’s Claude Partner Network Services Track, Strengthening Its AI-Led Engineering and Agentic AI Capabilities
Bharat Parenterals Ltd - Subsidiary Innoxel Lifesciences Commences US Commercial Supply, with More CMO Product Launches Expected Over the Next Two Quarters and into FY28
EMUDHRA - Added to watchlist. Let it reverse at least 5-7% from LC; then I’ll decide whether to enter or not. 😁
